Home/Pipeline/Tigilanol tiglate

Tigilanol tiglate

Soft tissue sarcoma, head and neck cancers

Phase 2Active

Key Facts

Indication
Soft tissue sarcoma, head and neck cancers
Phase
Phase 2
Status
Active
Company

About Qbiotics

Australian biotech leveraging rainforest‑derived small molecules for oncology and wound‑healing therapies.

View full company profile

Therapeutic Areas